In another blog recently, a couple of
doctors and I were lamenting about the state of affairs for the
National Diabetes Information Clearinghouse (NDIC). It seems that
the secretary for the Department of Health and Human Services (DHS)
is not concerned about the accuracy or completeness of the website
and may have ordered some of the information removed.
I am not saying that the current
secretary is involved, but it sure seems as if the former secretary,
Kathleen Sebelius may have done much of the damage. In November
2013, and earlier for other blogs, the information about Victoza
(liraglutide) was still on the website and I used the
information in several blogs. Then during the Spring of 2014, all
the information disappeared about Victoza. Other information that
was labeled black box information about two other injectable diabetes
drugs also disappeared although the remaining information has
remained for the drugs Symlin and Byetta or Bydureon.
The information is fortunately
available on the FDA site as a PDF file, this is the link. Victoza
is still available by prescription; people need to have a source for
the dangers of taking the drug.
Now, the other rub about the NDIC.
There have been two additional combo drugs added, but they have not
been included on the website. The newest diabetes drug class, SGLT2, Invokana and
two others in the class approved by the FDA are still absent from the
website.
We have to wonder why the website has
fallen into such bad times, or if it is the victim of the funds that
were directed elsewhere by an overly ambitious department head trying
to please her boss.
Either way, the NDIC is no longer a
dependable source for the discussion of diabetes medications, insulin
or oral pills.
No comments:
Post a Comment